MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY. Voprosy onkologii, v. 63, n. 6, p. 915–919, 1 Jun.2017.